JLABS @ Washington, DC: A Convergence Engine for Entrepreneurship

The Office of Technology Commercialization

Presents

Invention 2 Innovation (I2I)

“JLABS @ Washington, DC: A Convergence Engine for Entrepreneurship”

The Johnson & Johnson JLABS model is built to engage in external innovation and provide a pathway to commercialization for early-stage companies engaged in biotechnology research and development. Faculty, staff, clinicians, and entrepreneurs will learn about the unique capabilities of JLABS and the various ways they can engage with JLABS within our vibrant biotech ecosystem.

Wednesday, 26 May 2021
11:00 am – 12:00 pm

RSVP for Virtual Location

Presented By